Sign in

AbbVie Inc.

Income Statement - AbbVie Inc. (ABBV)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09
Total revenue 61.16 56.33 54.32 58.05 56.20 45.80 33.27 32.75 28.22 25.64 22.86 19.96 18.79 18.38 17.44 15.64 14.21
Cost of revenue 18.20 16.90 20.42 17.41 17.45 15.39 7.44 7.72 7.04 5.83 4.50 4.43 4.58 4.51 4.64 4.29 4.06
Gross profit 42.96 39.43 33.90 40.64 38.75 30.42 25.83 25.04 21.18 19.81 18.36 15.53 14.21 13.87 12.81 11.35 10.16
Total operating expenses + 22.87 30.29 21.15 22.52 20.83 19.05 12.84 18.65 11.63 10.47 10.82 12.12 8.55 8.06 9.19 6.63 5.23
Operating income 20.09 9.14 12.76 18.12 17.92 11.36 12.98 6.38 9.55 9.34 7.54 3.41 5.66 5.82 3.62 4.72 4.93
Non-operating income (net) -13.49 -5.42 -6.51 -4.64 -4.94 -7.97 -4.56 -1.19 -1.82 -1.46 -0.89 -1.04 -0.33 -0.09 0.05 0.12 1.02
Income before tax 6.60 3.72 6.25 13.48 12.99 3.40 8.43 5.20 7.73 7.88 6.65 2.37 5.33 5.73 3.67 4.84 5.95
Income tax expense 2.36 -0.57 1.38 1.63 1.44 -1.22 0.54 -0.49 2.42 1.93 1.50 0.60 1.20 0.45 0.24 0.66 1.31
Net income 4.23 4.28 4.86 11.84 11.54 4.62 7.88 5.69 5.31 5.95 5.14 1.77 4.13 5.28 3.43 4.18 4.64
Show Quarterly Income Statement

Income Statement - AbbVie Inc. (ABBV)

$(Billion, Million)
Jun-26 Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10
Total revenue 16.99 15.00 16.62 15.78 15.42 13.34 15.10 14.46 14.46 12.31 14.30 13.93 13.87 12.23 15.12 14.81 14.58 13.54 14.89 14.34 13.96 13.01 13.86 12.90 10.43 8.62 8.70 8.48 8.26 7.83 8.31 8.24 8.28 7.93 7.74 7.00 6.94 6.54 6.80 6.43 6.45 5.96 6.40 5.94 5.48 5.04 5.45 5.02 4.93 4.56 5.11 4.66 4.69 4.33 5.21 4.51 4.49 4.17 4.86 4.41 4.27 3.90 15.64
Cost of revenue 2.60 4.22 4.55 5.30 4.35 4.00 4.40 4.21 4.20 4.09 5.70 6.49 4.24 3.99 4.17 5.02 4.17 4.05 4.32 4.39 4.52 4.21 4.68 5.05 3.71 1.94 2.01 1.92 1.82 1.69 2.02 1.84 1.93 1.93 2.28 1.62 1.53 1.62 1.56 1.50 1.41 1.37 1.48 1.17 0.92 0.94 1.12 1.09 1.11 1.10 1.28 1.09 1.05 1.15 1.27 1.01 1.07 1.16 1.18 1.15 1.11 1.21 3.10
Gross profit 14.39 10.78 12.07 10.47 11.08 9.34 10.71 10.25 10.26 8.22 8.60 7.44 9.63 8.24 10.95 9.79 10.41 9.49 10.57 9.95 9.44 8.80 9.17 7.85 6.71 6.68 6.70 6.56 6.44 6.13 6.28 6.40 6.34 6.01 5.46 5.38 5.42 4.92 5.24 4.93 5.05 4.59 4.93 4.78 4.56 4.10 4.33 3.93 3.81 3.46 3.83 3.57 3.64 3.18 3.94 3.49 3.42 3.02 3.69 3.26 3.17 2.69 12.54
Total operating expenses + 7.67 6.05 6.26 8.57 6.18 5.61 12.20 6.42 6.26 5.42 5.40 5.16 5.11 5.47 5.45 5.19 7.12 4.77 5.49 5.65 5.00 4.69 5.42 4.60 5.96 3.07 2.74 3.94 3.04 3.12 8.72 3.24 3.58 3.10 3.67 2.69 2.75 2.52 2.88 2.57 2.66 2.31 2.81 2.89 2.71 2.41 4.75 2.97 2.30 2.11 2.29 2.20 2.19 1.87 2.12 1.90 2.00 2.04 2.31 3.21 1.80 1.87 0.00
Operating income 6.72 4.73 5.81 1.90 4.89 3.73 -1.49 3.83 4.00 2.80 3.20 2.28 4.51 2.77 5.50 4.60 3.30 4.72 5.07 4.31 4.44 4.10 3.75 3.26 0.75 3.60 3.96 2.62 3.40 3.01 -2.44 3.16 2.76 2.90 1.79 2.69 2.66 2.41 2.36 2.36 2.39 2.28 2.11 1.89 1.85 1.69 -0.42 0.96 1.52 1.35 1.54 1.37 1.45 1.31 1.82 1.60 1.42 0.98 1.38 0.05 1.36 0.82 5.18
Non-operating income (net) -2.45 -3.70 -3.14 -1.19 -3.34 -2.07 -0.78 -1.75 -1.85 -1.04 -1.98 -0.33 -1.90 -2.29 -2.54 -0.20 -2.11 0.21 -0.80 -0.62 -3.28 -0.24 -5.26 -0.76 -1.45 -0.51 -0.88 -0.62 -2.59 -0.47 0.07 -0.40 -0.75 -0.11 -0.60 -0.60 -0.31 -0.32 -0.36 -0.35 -0.29 -0.50 -0.19 -0.24 -0.17 -0.29 -0.62 -0.27 -0.08 -0.07 -0.10 -0.09 -0.09 -0.07 -0.11 0.01 -0.02 0.03 -0.02 0.02 0.02 0.03 -0.34
Income before tax 4.28 1.04 2.67 0.71 1.55 1.66 -2.27 2.08 2.15 1.76 1.21 1.95 2.61 0.48 2.97 4.40 1.18 4.93 4.27 3.69 1.16 3.87 -1.51 2.50 -0.69 3.10 3.07 2.00 0.81 2.54 -2.37 2.76 2.01 2.80 1.19 2.10 2.35 2.09 2.00 2.01 2.10 1.78 1.92 1.65 1.68 1.40 -1.04 0.69 1.43 1.29 1.44 1.29 1.37 1.24 1.71 1.60 1.40 1.01 1.36 0.07 1.38 0.86 4.84
Income tax expense 0.66 0.34 0.85 0.53 0.61 0.37 -2.25 0.52 0.77 0.38 0.39 0.17 0.58 0.23 0.49 0.45 0.26 0.44 0.23 0.51 0.39 0.31 -1.55 0.19 0.05 0.09 0.27 0.12 0.07 0.09 -0.55 0.01 0.03 0.01 1.14 0.46 0.44 0.38 0.61 0.42 0.49 0.42 0.41 0.41 0.31 0.37 -0.23 0.18 0.34 0.31 0.31 0.32 0.30 0.27 0.17 0.02 0.14 0.12 0.20 0.06 -0.16 0.14 0.66
Net income 3.62 0.70 1.82 0.19 0.94 1.29 -0.02 1.56 1.37 1.37 0.82 1.78 2.02 0.24 2.47 3.95 0.92 4.49 4.04 3.18 0.77 3.55 0.04 2.31 -0.74 3.01 2.80 1.88 0.74 2.46 -1.83 2.75 1.98 2.78 0.05 1.63 1.92 1.71 1.39 1.60 1.61 1.35 1.52 1.24 1.37 1.02 -0.81 0.51 1.10 0.98 1.13 0.96 1.07 0.97 1.54 1.59 1.27 0.88 1.16 0.01 1.54 0.72 4.18
about 2 months ago

Balance Sheet - AbbVie Inc. (ABBV)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09
Total cash and short-term investments + 5.26 5.56 12.82 9.23 9.83 8.48 39.92 8.06 9.79 6.42 8.41 8.37 9.90 7.98 0.65 0.01 0.00
Accounts receivable, net 12.59 10.92 11.16 11.25 9.98 8.82 5.43 5.38 5.09 4.76 4.73 3.74 4.80 4.30 3.82 3.37
Inventories 4.95 4.18 4.10 3.58 3.13 3.31 1.81 1.61 1.61 1.44 1.72 1.12 1.15 1.09 0.87 0.84
Other current assets 6.27 4.93 4.93 4.40 4.99 3.56 2.35 1.90 4.74 3.56 1.46 2.85 2.00 1.99 2.01 4.00
Total current assets 29.06 25.58 33.00 28.46 27.93 24.17 49.52 16.95 21.22 16.19 16.31 16.08 17.85 15.35 7.35 8.22
Total non-current assets + 104.90 109.58 101.71 110.34 118.60 126.39 39.60 42.41 49.56 49.91 36.74 11.43 11.35 11.65 12.17 12.92
Total assets 133.96 135.16 134.71 138.81 146.53 150.57 89.12 59.35 70.79 66.10 53.05 27.51 29.20 27.01 19.52 21.13
Total current liabilities + 43.29 38.75 37.84 29.54 35.19 28.66 15.59 17.24 16.64 9.78 10.89 11.39 6.88 6.78 5.90 3.76
Total non-current liabilities + 93.90 93.05 86.47 91.98 95.90 108.81 81.70 50.56 49.05 51.68 38.21 14.38 17.83 16.87 1.69 1.67
Total liabilities 137.19 131.80 124.31 121.52 131.09 137.47 97.29 67.80 65.69 61.46 49.11 25.77 24.71 23.65 7.59 5.43
Total stockholders' equity + -3.23 3.36 10.40 17.29 15.44 13.10 -8.17 -8.45 5.10 4.64 3.95 1.74 4.49 3.36 11.93 15.70
Common shares outstanding 1,774 1,773 1,773 1,778 1,777 1,673 1,484 1,546 1,603 1,631 1,637 1,610 1,604 1,577 1,625 1,625 1,625
Show Quarterly Balance Sheet

Balance Sheet - AbbVie Inc. (ABBV)

$(Billion, Million)
Jun-26 Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10
Total cash and short-term investments + 0.00 9.39 5.26 5.67 6.47 5.18 5.56 7.29 13.16 18.07 12.82 13.29 8.77 6.72 9.23 11.88 9.96 7.57 9.83 12.25 8.60 9.78 8.48 7.95 6.04 41.14 39.92 10.65 5.42 5.23 8.06 8.79 3.74 9.47 9.79 9.55 7.21 6.25 6.42 7.95 8.00 8.60 8.41 9.25 8.28 7.92 8.37 7.73 10.25 9.10 9.90 9.60 8.75 7.48 7.98 4.59 0.07 0.04 0.65 0.00 0.00 0.00 1.88
Accounts receivable, net 12.48 12.59 12.77 12.64 12.48 10.92 11.47 11.72 11.95 11.16 11.41 11.49 11.47 11.25 10.74 11.24 10.73 9.98 9.28 9.91 9.59 8.82 8.42 8.35 6.36 5.43 5.53 5.48 5.68 5.38 5.78 5.79 5.84 5.09 4.89 4.86 4.68 4.76 5.00 5.05 4.75 4.73 4.57 4.37 4.21 3.74 3.06 3.13 3.11 4.80 3.80 3.76 4.30 4.30 3.10 2.99 3.65 3.82
Inventories 5.05 4.95 4.94 4.96 4.53 4.18 4.45 4.22 4.25 4.10 3.98 4.06 3.83 3.58 3.17 3.40 3.48 3.13 3.09 3.39 3.27 3.31 3.47 4.06 1.84 1.81 1.93 1.90 1.70 1.61 1.79 1.58 1.74 1.61 1.79 1.58 1.43 1.44 1.63 1.76 1.79 1.72 1.84 1.62 1.02 1.12 1.01 1.05 1.10 1.15 1.17 1.09 1.04 1.09 0.96 0.86 0.92 0.87 0.84
Other current assets 6.61 6.27 5.16 5.20 5.50 4.93 4.58 4.72 4.61 4.93 4.54 4.54 4.46 4.40 4.57 4.51 4.72 4.99 4.33 4.10 3.93 3.56 3.17 2.80 2.41 2.35 2.06 2.31 1.80 1.90 2.11 2.73 3.39 4.74 2.70 3.32 3.20 3.56 1.71 1.99 1.48 1.46 2.25 2.61 2.25 2.85 5.76 3.37 4.02 2.00 1.98 2.07 2.11 1.99 2.29 2.06 2.15 2.01 2.13
Total current assets 33.53 29.06 28.54 29.26 27.68 25.58 27.79 33.82 38.87 33.00 33.22 28.85 26.49 28.46 30.36 29.10 26.51 27.93 28.96 26.00 26.57 24.17 23.01 21.26 51.76 49.52 20.17 15.10 14.41 16.95 18.47 13.85 20.44 21.22 18.93 16.96 15.55 16.19 16.29 16.79 16.62 16.31 17.91 16.88 15.41 16.08 17.56 17.79 17.33 17.85 16.54 15.66 14.92 15.35 10.93 5.99 6.75 7.35
Total non-current assets + 102.93 104.90 105.36 107.92 108.49 109.58 115.64 108.12 110.00 101.71 103.00 106.52 108.06 110.34 110.96 114.09 116.70 118.60 119.90 121.97 123.93 126.39 126.61 128.27 39.44 39.60 39.28 42.04 42.36 42.41 47.70 47.80 48.90 49.56 49.91 50.03 50.12 49.91 50.34 50.42 37.10 36.74 36.92 36.98 11.29 11.43 10.90 11.25 11.33 11.35 11.71 12.25 12.25 11.65 11.80 11.72 12.21 12.17
Total assets 136.46 133.96 133.90 137.18 136.17 135.16 143.42 141.94 148.87 134.71 136.22 135.37 134.54 138.81 141.33 143.19 143.21 146.53 148.86 147.97 150.50 150.57 149.62 149.53 91.20 89.12 59.44 57.14 56.77 59.35 66.16 61.64 69.34 70.79 68.84 66.99 65.66 66.10 66.63 67.21 53.72 53.05 54.83 53.86 26.70 27.51 28.45 29.05 28.66 29.20 28.25 27.91 27.17 27.01 22.73 17.71 18.96 19.52 21.13
Total current liabilities + 42.10 43.29 39.39 39.77 36.40 38.75 43.06 41.92 41.52 37.84 34.77 32.24 27.59 29.54 32.71 34.47 32.52 35.19 28.53 28.68 31.95 28.66 24.18 24.65 16.47 15.59 17.49 16.94 13.90 17.24 15.39 17.22 17.06 16.64 13.03 12.26 8.84 9.78 9.10 9.27 10.66 10.89 8.81 11.26 11.05 11.39 6.64 6.32 6.22 6.88 6.88 6.81 6.77 6.78 5.37 4.84 5.51 5.90 3.76
Total non-current liabilities + 66.86 93.90 97.11 97.55 98.30 93.05 94.29 93.20 99.31 86.47 89.32 90.23 93.65 91.98 92.59 94.03 94.38 95.90 106.75 106.69 104.82 108.81 110.15 110.15 82.14 81.70 50.17 48.77 50.69 50.56 53.70 47.79 48.73 49.05 49.12 48.73 51.82 51.68 51.05 52.30 38.42 38.21 41.16 37.09 14.27 14.38 17.17 17.51 17.74 17.83 17.80 17.55 17.45 16.87 1.69 1.36 1.40 1.69
Total liabilities 143.08 137.19 136.50 137.32 134.70 131.80 137.35 135.12 140.83 124.31 124.09 122.47 121.24 121.52 125.30 128.50 126.90 131.09 135.28 135.38 136.77 137.47 134.33 134.80 98.61 97.29 67.67 65.71 64.60 67.80 69.09 65.02 65.79 65.69 62.15 60.99 60.67 61.46 60.16 61.57 49.08 49.11 49.97 48.35 25.32 25.77 23.81 23.83 23.96 24.71 24.68 24.35 24.21 23.65 7.06 6.20 6.91 7.59 5.43
Total stockholders' equity + -6.61 -3.23 -2.60 -0.14 1.46 3.36 6.07 6.82 8.05 10.40 12.13 12.90 13.30 17.29 16.03 14.69 16.31 15.44 13.58 12.59 13.73 13.10 15.29 14.73 -7.42 -8.17 -8.23 -8.57 -7.83 -8.45 -2.92 -3.38 3.55 5.10 6.69 6.01 5.00 4.64 6.47 5.64 4.64 3.95 4.86 5.50 1.38 1.74 4.65 5.22 4.70 4.49 3.58 3.56 2.96 3.36 15.67 11.51 12.05 11.93 15.70
Common shares outstanding 1,771 1,774 1,774 1,772 1,772 1,772 1,773 1,772 1,771 1,773 1,772 1,771 1,771 1,776 1,778 1,776 1,776 1,778 1,778 1,777 1,776 1,775 1,781 1,774 1,647 1,484 1,485 1,483 1,484 1,483 1,481 1,515 1,572 1,596 1,602 1,603 1,600 1,603 1,623 1,640 1,632 1,625 1,640 1,664 1,633 1,608 1,597 1,610 1,608 1,609 1,608 1,605 1,609 1,605 1,605 1,580 1,625 1,625 1,580 1,580 1,580 1,625
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09
Operating cash flow + 19.03 18.81 22.84 24.94 22.78 17.59 13.32 13.43 9.96 7.04 7.54 3.55 6.27 6.35 6.25 4.98 5.37
Cash flow from investing + -6.64 -20.82 -2.01 -0.62 -2.34 -37.56 0.60 -1.01 -0.27 -6.07 -12.94 -0.93 0.88 -2.42 0.55 -5.03 -0.49
Cash flow from financing + -12.72 -5.21 -17.22 -24.80 -19.04 -11.50 18.71 -14.40 -5.51 -3.93 5.75 -3.29 -3.44 1.93 -6.78 0.07 -4.88
Change in cash -0.34 -7.23 3.61 -0.48 1.30 -31.48 32.64 -2.01 4.20 -3.30 0.05 -1.25 3.69 5.86 0.02 0.01 0.00
Change in exchange rate -0.10 -0.01 0.01 -0.04 0.03 -0.34 -0.30 -0.58 -0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10
Operating cash flow + 3.83 5.22 7.02 5.15 1.64 7.05 5.45 2.27 4.04 4.75 7.57 6.32 4.19 7.43 7.60 5.01 4.91 5.08 7.94 4.89 4.88 4.85 5.83 3.09 3.82 3.28 4.56 2.48 3.02 3.39 4.52 2.87 2.65 2.58 3.27 2.00 2.10 1.54 1.45 1.92 2.13 1.96 2.16 1.83 1.59 -0.58 1.79 1.72 0.62 1.25 1.80 2.04 1.19 0.94 2.25 1.56 1.59 1.05 1.77 2.15 1.28 4.98
Cash flow from investing + -0.57 -1.46 -3.26 -1.18 -0.74 -1.87 -8.26 -1.10 -9.59 -0.80 -0.37 -0.34 -0.50 -0.45 1.29 0.13 -1.59 -1.15 -0.62 -0.24 -0.34 -0.63 -1.15 -35.65 -0.13 -0.62 1.38 -0.14 -0.03 -0.28 -0.96 0.69 -0.45 0.20 -0.11 0.32 -0.68 -0.12 -0.20 -4.30 -1.46 -0.30 0.75 -12.51 -0.87 2.51 -2.28 -0.36 -0.80 0.12 -0.96 0.23 1.49 -0.21 -1.81 -0.20 -0.20 0.51 0.47 -0.35 -0.08
Cash flow from financing + 0.92 -4.17 -4.59 -2.71 -1.26 -6.86 -3.07 -6.10 10.82 -4.45 -2.66 -3.92 -6.19 -9.63 -5.52 -2.68 -6.97 -6.34 -3.64 -5.88 -3.17 -3.70 -2.81 -2.57 -2.42 26.60 -0.44 -2.07 -5.38 -3.83 0.92 -8.98 -2.51 -1.93 -0.81 -0.98 -1.79 -2.50 -1.37 1.16 -1.22 -2.43 -1.06 10.17 -0.93 -0.88 -0.72 -0.42 -1.28 -0.75 -0.61 -0.50 -1.58 2.39 2.24 -1.33 -1.38 -1.56 -2.25 -1.77 -1.20 0.07
Change in cash 4.17 -0.41 -0.83 1.26 -0.36 -1.69 -5.88 -4.93 5.27 -0.50 4.54 2.06 -2.50 -2.65 3.37 2.42 -3.65 -2.44 3.64 -1.21 1.31 0.56 1.87 -35.13 1.22 29.28 5.48 0.28 -2.39 -0.73 4.47 -5.46 -0.30 0.86 2.36 1.35 -0.36 -1.12 -0.11 -1.23 -0.84 -0.82 1.82 -0.51 -0.44 0.63 -1.37 0.95 -1.46 0.62 0.23 1.76 1.08 3.12 2.69 0.03 0.01 0.00 -0.01 0.03 0.00 5.04
Change in exchange rate -0.03 0.01 -0.03 -0.04 0.03 -0.06 0.03 0.01 0.01 -0.05 0.01 -0.02 0.01 0.00 -0.01 -0.01 -0.04 0.02 0.01 0.01 0.02 -0.04 0.01 -0.01 -0.29 -0.06 -0.02 0.00 -0.22 -0.43 -0.15 0.00 -0.01 0.00 0.01 -0.01 -0.01
about 2 months ago

AbbVie Inc. (ABBV) - Shares Outstanding Diluted

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Change In Exchange Rate

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Net Income

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

AbbVie Inc. (ABBV) - Change In Inventory

1Y 2Y 5Y Max
about 2 months ago